[go: up one dir, main page]

WO2006012237A3 - Aripiprazole crystaline forms and associated methods - Google Patents

Aripiprazole crystaline forms and associated methods Download PDF

Info

Publication number
WO2006012237A3
WO2006012237A3 PCT/US2005/022327 US2005022327W WO2006012237A3 WO 2006012237 A3 WO2006012237 A3 WO 2006012237A3 US 2005022327 W US2005022327 W US 2005022327W WO 2006012237 A3 WO2006012237 A3 WO 2006012237A3
Authority
WO
WIPO (PCT)
Prior art keywords
aripiprazole
associated methods
crystaline
forms
crystaline forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/022327
Other languages
French (fr)
Other versions
WO2006012237A2 (en
Inventor
Qingwen Zhang
Yan-Yan Xu
Huilin Shi
Xia Yin
Xiaojin Xi
Dianguo Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Actavis Laboratories UT Inc
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Actavis Laboratories UT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry, Actavis Laboratories UT Inc filed Critical Shanghai Institute of Pharmaceutical Industry
Publication of WO2006012237A2 publication Critical patent/WO2006012237A2/en
Publication of WO2006012237A3 publication Critical patent/WO2006012237A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A crystal form of anhydrous aripiprazole having good stability, which can be prepared by simple and economical processes, including such processes are disclosed and described. In one aspect, such a process may include dissolving aripiprazole in an appropriate solvent by heating, and then rapidly cooling with agitation of high speed, to cause the anhydrous aripiprazole of crystal a to swiftly and uniformly precipitate.
PCT/US2005/022327 2004-06-25 2005-06-24 Aripiprazole crystaline forms and associated methods Ceased WO2006012237A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58330304P 2004-06-25 2004-06-25
US60/583,303 2004-06-25
US16646505A 2005-06-23 2005-06-23
US11/166,465 2005-06-23

Publications (2)

Publication Number Publication Date
WO2006012237A2 WO2006012237A2 (en) 2006-02-02
WO2006012237A3 true WO2006012237A3 (en) 2006-12-21

Family

ID=35786664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/022327 Ceased WO2006012237A2 (en) 2004-06-25 2005-06-24 Aripiprazole crystaline forms and associated methods

Country Status (1)

Country Link
WO (1) WO2006012237A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7714129B2 (en) 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
JP5546717B2 (en) 2003-12-16 2014-07-09 テバ ファーマシューティカル インダストリーズ リミティド Method for preparing aripiprazole crystalline form
CA2605128A1 (en) * 2005-04-15 2007-01-11 Medichem, S.A. Syntheses and preparations of polymorphs of crystalline aripiprazole
WO2008020453A2 (en) * 2006-08-17 2008-02-21 Unichem Laboratories Limited A process for the preparation of a novel crystalline polymorph of aripiprazole
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
WO2008059518A2 (en) * 2006-09-28 2008-05-22 Cadila Healthcare Limited Process for preparing crystalline aripiprazole
WO2008051541A2 (en) 2006-10-24 2008-05-02 Cambrex Charles City, Inc. Process for preparing anhydrous aripirazole type i
EP2238976B1 (en) 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
CN119306661A (en) * 2024-10-14 2025-01-14 广东工业大学 A method for simultaneously regulating aripiprazole new crystal form and crystal habit and new crystal form thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Also Published As

Publication number Publication date
WO2006012237A2 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
Haidenbauer et al. Hyperon–nucleon interaction at next-to-leading order in chiral effective field theory
WO2009080611A3 (en) Process for producing surface-crosslinked superabsorbents
WO2006012237A3 (en) Aripiprazole crystaline forms and associated methods
NZ603918A (en) Improved methods for preparing squalene
EP3473372A3 (en) Laser cutting strengthened glass
WO2005101266A3 (en) Apparatus and method for facilitating a search for gem settings
WO2010120515A3 (en) Methods for producing cultured pearls in conch and other gastropods
MX2010003970A (en) Method for the preparation of organic nitrates.
WO2015048426A3 (en) Methods of making rosin esters
WO2009094717A3 (en) A method of inducing tolerance to an allergen
MY174160A (en) Polyvinylidene fluoride resin particles and method for producing same
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
WO2011084663A3 (en) Controlling the detectability of an article and method for authenticating the article
NZ610378A (en) Lipoyl compounds and their use for treating ischemic injury
WO2012064477A3 (en) Compositions comprising cis-1,1,1,4,4,4-hexafluoro-2-butene and 2-difluoromethoxy-1,1,1,2-tetrafluoroethane and uses thereof
GEP20135926B (en) Trazodone and trazodone hydrochloride in purified form
WO2008088776A3 (en) Amorphous drug beads
AU2010271717A8 (en) Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
EP1792919A4 (en) PROCESS FOR PRODUCING HOMOPOLYMER VINYLIDENE FLUORIDE HAVING TYPE I CRYSTAL STRUCTURE
WO2006052787A3 (en) Liquefaction of starch-containing material
MX2017008461A (en) Method and device for assembling automobile body.
WO2008132412A3 (en) Method for decontaminating a solution with respect to unwanted nucleic acids
EP2057899A3 (en) Method for making cyclopropene inclusion complex
CN103725831B (en) The hardening and tempering process of alloy steel pipe
WO2010040761A3 (en) Process for producing mixed metal rare earth metal halide solutions in organic solvents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase